IONS
IONS
NASDAQ · Biotechnology

Ionis Pharmaceuticals Inc

Mid-Cap Stocks Biotech Stocks Healthcare Stocks
$44.90
+0.46 (+1.04%)
As of Sep 21, 9:43 PM ET ·
Analyst Consensus
Strong Buy
32
Analysts
Very High
Coverage
Buy 25 78%
Hold 7 22%
Sell 0 0%
Price Target
Analyst Price Target +66.9% upside
Low Target $58.43
Average Target $74.94
High Target $113.95
Current Price $44.90
Current
$44.90
Target
$74.94
$58.43 $74.94 avg $113.95
Scenario Analysis
Bear Case
$58.43
30.1%
Low target
Base Case
$74.94
+66.9%
Avg target
Bull Case
$113.95
+153.8%
High target
Risk/Reward
5.1x
Highly favorable
Price in Context
52-Week High
$86.74
-48.2% from high
52-Week Low
$44.66
+0.5% from low
50-Day SMA
$80.92
-44.5% vs SMA
200-Day SMA
$60.03
-25.2% vs SMA
RSI (14)
47.8
Neutral
Target vs 52W High
$74.94
-13.6% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 39 82% $257.58 -2.6%
AMGN
Amgen Inc
 Hold 43 47% $190.87 -51.5%
GILD
Gilead Sciences Inc
 Strong Buy 37 81% $362.68 +140.9%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 36 81% $438.34 -14.2%
REGN
Regeneron Pharmaceuticals
 Buy 38 68% $76.80 -90.4%
MRNA
Moderna Inc
 Hold 30 37% $149.45 -13.6%
NTRA
Natera Inc
 Strong Buy 30 87% $142.91 -61.4%
RVMD
Revolution Medicines Inc
 Strong Buy 28 93% $114.11 -40.8%